Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

WIN Symposium 2017

26 - 27 Jun 2017
Hotel Novotel Paris Tour Eiffel, Paris, France
WIN 2017 conference review
Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncolog...
WIN 2017 conference review ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
5 Jul 2017
Molecular medicine in lung cancer
Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany
Molecular medicine in lung cancer ( Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany )
4 Jul 2017
Biomarker research in breast cancer
Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium
Biomarker research in breast cancer ( Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium )
4 Jul 2017
New biomarkers for response to immunotherapy
Prof Antoni Ribas - University of California, Los Angeles, USA
New biomarkers for response to immunotherapy ( Prof Antoni Ribas - University of California, Los Angeles, USA )
4 Jul 2017
Combining immune-based therapies with TKIs in melanomas
Prof Caroline Robert - Institute Gustave Roussy, Paris, France
Combining immune-based therapies with TKIs in melanomas ( Prof Caroline Robert - Institute Gustave Roussy, Paris, France )
4 Jul 2017
Current and future immune approaches in precision medicine
Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France
Current and future immune approaches in precision medicine ( Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France )
4 Jul 2017
Precision medicine enabled histology agnostic development of immunotherapeutics
Dr Roy Baynes - Merck Research Laboratories, Rahway, USA
Precision medicine enabled histology agnostic development of immunotherapeutics ( Dr Roy Baynes - Merck Research Laboratories, Rahway, USA )
4 Jul 2017
Incorporating liquid biopsies into clinical trials
Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor,...
Incorporating liquid biopsies into clinical trials ( Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor,  USA )
4 Jul 2017
DNA damage response inhibition
Dr Giorgio Massimini - Vice President, Head of Early Clinical Oncology, Merck, D...
DNA damage response inhibition ( Dr Giorgio Massimini - Vice President, Head of Early Clinical Oncology, Merck, Darmstadt, Germany )
4 Jul 2017
Big data, scientific wellness and transforming healthcare
Prof Leroy Hood - Systems Biology, Seattle, USA
Big data, scientific wellness and transforming healthcare ( Prof Leroy Hood - Systems Biology, Seattle, USA )
4 Jul 2017
Bayesian adaptive trial designs for precision medicine
Dr Jack Lee - MD Anderson Cancer Center, Houston, USA
Bayesian adaptive trial designs for precision medicine ( Dr Jack Lee - MD Anderson Cancer Center, Houston, USA )
4 Jul 2017
Redesigning clinical trials in the era of precision medicine
Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA
Redesigning clinical trials in the era of precision medicine ( Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA )
4 Jul 2017
Genomic-driven clinical studies in breast cancer
Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Genomic-driven clinical studies in breast cancer ( Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jul 2017
Genomic predictors of treatment response in prostate cancer
Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada
Genomic predictors of treatment response in prostate cancer ( Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jul 2017
Synthetic lethality as a basis to select drug combinations
Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland
Synthetic lethality as a basis to select drug combinations ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland )
4 Jul 2017
Genomic analysis of childhood tumours; biological and therapeutic implications
Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany
Genomic analysis of childhood tumours; biological and therapeutic implications ( Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany )
4 Jul 2017
Patient-specific peptide vaccines
Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany
Patient-specific peptide vaccines ( Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany )
4 Jul 2017
Proteogenomics in cancer research
Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA
Proteogenomics in cancer research ( Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA )
4 Jul 2017
Novel models to personalise cancer therapeutics
Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden
Novel models to personalise cancer therapeutics ( Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden )
4 Jul 2017